NCT04031521
Withdrawn
Not Applicable
Near-infrared Spectroscopy in Sickle Cell Pediatric Patients During Pain Crisis and After Recovery
Children's National Research Institute1 site in 1 countryJune 26, 2019
ConditionsSickle Cell Disease
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Sickle Cell Disease
- Sponsor
- Children's National Research Institute
- Locations
- 1
- Primary Endpoint
- Tissue oxygenation
- Status
- Withdrawn
- Last Updated
- 2 years ago
Overview
Brief Summary
Endothelial dysfunction contributes to vaso-occlusion and acute pain in sickle cell disease. Near infrared spectroscopy (NIRS) technology can measure tissue oxygenation and endothelial function. The main objective of this study is to study the natural history of tissue muscle oxygenation using NIRS in pediatric sickle cell subjects experiencing acute pain and pediatric sickle cell patients in steady-state.
Investigators
Suvankar Majumdar
Chief of Hematology
Children's National Research Institute
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Tissue oxygenation
Time Frame: 6 months
Secondary Outcomes
- Nitric oxide(6 months)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Exploring Near Infrared Spectroscopy (NIRS) Technologies for Assessment of Muscle Physiology, Tissue Oxygenation, and Blood Flow in Patients With Sickle Cell Disease (SCD)SCDNCT05604547National Heart, Lung, and Blood Institute (NHLBI)49
Completed
Not Applicable
Hemostasis in Sickle Cell Disease--Infancy to AdulthoodAnemia, Sickle CellBlood DiseaseNCT00005703National Heart, Lung, and Blood Institute (NHLBI)
Completed
Not Applicable
Evaluation of Non-invasive Endothelial Function in Children Sickle by Vascular UltrasoundSickle Cell DiseaseNCT02829580University Hospital, Toulouse31
Recruiting
Not Applicable
A Pilot Study on Neuroimaging in SCD: Part of The Boston Consortium to Cure Sickle Cell DiseaseSickle Cell DiseaseNCT04166526Boston Children's Hospital8
Not yet recruiting
Phase 2
A clinical trial to determine safety and efficacy of Sailin-HbS in Sickle cell disease patientsCTRI/2024/04/066222Indian Council for Medical Research